Revolutionary research shows statins combined with new PIN1 inhibitors could transform bladder cancer treatment, offering hope to thousands of patients.
With a new potential drug target for bladder cancer therapy identified, the scientists found that a combination of the statin simvastatin and a PIN1 inhibitor called sulfopin helped stop bladder ...